A reformulated version of an anti-HIV gel was found safe and acceptable by HIV-negative men and women who used it rectally. The gel is developed for vaginal use.
This is according to a Phase I clinical trial published in iPLOS ONE/i. The study, led by researchers with the U.S. National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), tested a reduced glycerin formulation of tenofovir gel, and has spurred the development of an expanded safety study of the gel, expected to launch later this year....
A reformulated version of an anti-HIV gel was found safe and acceptable by HIV-negative men and women who used it rectally. The gel is developed for vaginal use.
This is according to a Phase I clinical trial published in iPLOS ONE/i. The study, led by researchers with the U.S. National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), tested a reduced glycerin formulation of tenofovir gel, and has spurred the development of an expanded safety study of the gel, expected to launch later this year....
